IPO Date: 10 Jan - 14 Jan 2025
Listing Date: 17 Jan 2025
Price Range
₹77 – ₹81
Issue Size
34 Cr
Min Investment
₹1,23,200
Lot Size
1600 Shares
Issue open date
10 Jan 2025
Issue close date
14 Jan 2025
UPI mandate deadline
14 Jan 2025 (5 PM)
Allotment finalization
15 Jan 2025
Share credit
16 Jan 2025
Listing date
17 Jan 2025
Mandate end date
29 Jan 2025
Funds Raised in the IPO | Amount |
---|---|
Overall | 34 Cr |
Fresh Issue | 33.8 Cr |
Offer for Sale | 0 Cr |
Allotment Timeline | Details |
---|---|
Allotment Date | 15 Jan 2025 |
Allotment Link | {Link} |
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
Date | Ipo Price | GMP | Estimated Listing Price |
---|---|---|---|
17 Jan 2025 | ₹81 | ₹40 | ₹121 (49.38%) |
16 Jan 2025 | ₹81 | ₹40 | ₹121 (49.38%) |
15 Jan 2025 | ₹81 | ₹49 | ₹130 (61%) |
14 Jan 2025 | ₹81 | ₹60 | ₹141 (74%) |
13 Jan 2025 | ₹81 | ₹30 | ₹111 (37%) |
11 Jan 2025 | ₹81 | ₹32 | ₹113 (40%) |
10 Jan 2025 | ₹81 | ₹32 | ₹113 (40%) |
9 Jan 2025 | ₹81 | ₹24 | ₹105 (30%) |
8 Jan 2025 | ₹81 | ₹10 | ₹91 (12%) |
Issue Price | Listing Gain | Current Market Price | P/L |
---|---|---|---|
₹77 – ₹81 | ₹ 160 (99.44%) | ₹ 147.5 | 82.10% |
Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company offering natural wellness solutions. The company specializes in therapeutic and lifestyle products based on traditional Ayurveda practices, targeting areas such as addiction, diabetes, joint pain, and mental wellness. It sells its products directly to consumers through its website, third-party e-commerce platforms, TV marketing, and digital channels. They operate with contract manufacturers for production, focusing on product development and distribution.
Founded in | 2012 |
Managing director | Mr. Ved Prakash |
Parent organization | Sat Kartar Shopping Ltd |
Category | Subscription (No. of times) |
---|---|
Qualified Institutional Buyers (QIBs) | 124 |
Non-Institutional Investors (NIIs) | 808 |
Retail Individual Investors (RIIs) | 250 |
Employee | N/A |
Total | 332 |